Sun Pharma is a wholly owned subsidiary of Sun Pharmaceutical Industries Limited (SPIL). SPIL is the
world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by
customers and patients in over 100 countries across the world, at affordable prices. Its global presence is
supported by manufacturing facilities spread across 6 continents and approved by multiple regulatory
agencies, coupled with a multi-cultural workforce comprising over 50 nationalities. SPIL fosters excellence
through innovation supported by strong R&D capabilities across multiple R&D centers, with investments
of approximately 6% of annual revenues in R&D. For further information, please visit
www.sunpharma.com & follow us on Twitter @SunPharma_Live.